Research & Education

IASLC European Webinar Series - 2015/2016 - Staging of Lung Cancer - 2015

Wednesday, October 14, 2015 - 7 p.m. CEST - Recording Available
 Ramon Rami-Porta

Prof. Ramon Rami-Porta, MD
Attending Thoracic Surgeon,
Department of Thoracic Surgery
Hospital Universitari Mutua Terrassa,
University of Barcelona, Terrassa,
Barcelona, Spain

Name of Reviewer(s): 

              

Laurie Gaspar, MD –Nothing to disclose

Name of Planner(s): 

 

     Deb Whippen-Nothing to Disclose

Name of Activity: 

 

Staging of Lung Cancer - 2015

Date of Activity:

 

10/14/2015

Faculty/Speaker(s):

Financial DISCLOSURES

 

Moderator – Franco Foti- Nothing to Disclose

Speaker- Prof. Ramon Rami-Porta, MD- Nothing to Disclose

Type of Activity: 

 Live Course

  Internet Live Course (Webinar)XXXX

 Internet Enduring Material

Are there Commercial Supporters for this activity?

       Yes   

If yes, please list: Supported by an unrestricted grant from Genentech, Bristol-Meyers Squibb and Celgene.

 

This presentation will describe the IASLC database used for the revision of the current, 7th edition, of the TNM classification for lung cancer. The recommendations of the IASLC Staging and Prognostic Factors Committee for changes in the T, the N and the M components of the classification, and in the stage grouping will be reviewed and discussed.

After viewing this program attendees will:

  • Demonstrate the current 7th edition of the TNM classification for lung cancer.
  • Recognize the data used to support changes in the T,N and M components of the classification.
  • Identify the practical implications of using the revised TNM classification for lung cancer.

This CME live webinar series is designed to meet the educational needs of healthcare professionals who diagnose and treat patients with lung cancer, including medical oncologists, thoracic surgeons, pulmonologists, radiation oncologists, radiologists, pathologists and advanced practice nurses and physicians' assistants.

 

Registration is on a first-come, first-served basis, participation is limited.

CME INFORMATION:

Financial/Commercial Relationships DISCLOSURES

A Conflict of Interest (COI) is created and exists when individuals in a position to control the content of CME, or their spouses/partners, that have a relevant personal financial relationship within the past 12 months with a commercial interest that produces, markets, re-sells, or distributes health care goods or services consumed by, or used, on patients that benefits the individual in any financial amount and therefore, may bias their opinions and teachings. This may include receiving a salary, royalty, intellectual property rights, consulting fee, honoraria, ownership interest (e.g., stocks, stock options or other ownership interest, excluding diversified mutual funds), or any other financial benefit. Financial benefits are usually associated with roles such as employment, management position, independent contractor (including contracted research and clinical trials), consulting, speaking and teaching, membership on advisory committees or review panels, board membership, and other activities for which remuneration is received or expected. 

 This IASLC CME educational activity was planned and developed to: uphold academic standards to ensure balance, independence, objectivity, and scientific rigor; adhere to requirements to protect health information under the Health Insurance Portability and Accountability Act of 1996 (HIPAA); and, include a mechanism to inform learners when unapproved or unlabeled uses of therapeutic products or agents are discussed or referenced.

IASLC CME assures that the planners/reviewers/authors/faculty/moderators/peer reviewers et. al. conflicts of interest  were identified, reviewed and resolved from all individuals involved in the development  or able to influence and control the content of this CME activity; IASLC CME assures that disclosure is given prior to an educational activity being delivered to learners.  Any individual who failed or refused to disclose relevant financial relationships was disqualified from this CME activity and removed from any of IASLC CME activity presentation.

All commercial relationships and conflicts of interest that are identified are thoroughly vetted by IASLC Ethics Committee, CME Subcommittee, and Independent reviewer. COI will be evaluated by the Board of Directors of the IASLC for fair balance, scientific objectivity of studies utilized in this activity, and patient care recommendations. IASLC CME is committed to providing its learners with high-quality CME activities and related materials that promote improvements or quality in health care and not a specific proprietary business interest of a commercial entity.

CREDIT STATEMENT

IASLC is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

IASLC CME designates this Internet Live Course activity for a maximum of 1 AMA PRA Category 1 Credits™.  Physicians should claim only the credit commensurate with the extent of their participation in the activity.

GOAL & PURPOSE

This presentation will describe the IASLC database used for the revision of the current, 7th edition, of the TNM classification for lung cancer. The recommendations of the IASLC Staging and Prognostic Factors Committee for changes in the T, the N and the M components of the classification, and in the stage grouping will be reviewed and discussed.

TARGET AUDIENCE

This CME live webinar series is designed to meet the educational needs of healthcare professionals who diagnose and treat patients with lung cancer, including medical oncologists, thoracic surgeons, pulmonologists, radiation oncologists, radiologists, pathologists and advanced practice nurses and physicians' assistants.

DISCLAMER

Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patient’s conditions and possible contraindications on dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities.

Thank you for your participation.

DOWNLOAD RECORDING

 

IASLC Financial/Commercial Relationships and Conflicts of Interest Policy

IASLC Honoraria Policy

IASLC Commercial Support Agreement (LOA)

If you are interested in obtaining the CME Credits for these sessions you must indicate this when you register for the program. CME credit is only available to attendees of the live webinar.

Location Local time Time zone UTC offset
New York (U.S.A. - New York) Wednesday, October 14, 2015 at 10:00:00 PM EDT UTC-4 hours
Barcelona (Spain) Wednesday, October 14, 2015 at 7:00:00 PM CEST UTC+2 hours
London (United Kingdom) Wednesday, October 14, 2015 at 6:00:00 PM BST UTC+1 hour
Paris (France) Wednesday, October 14, 2015 at 7:00:00 PM CEST UTC+2 hours
Amsterdam (Netherlands) Wednesday, October 14, 2015 at 7:00:00 PM CEST UTC+2 hours
Moscow (Russia) Wednesday, October 14, 2015 at 8:00:00 PM MSK UTC+3 hours
Rome (Italy) Wednesday, October 14, 2015 at 7:00:00 PM CEST UTC+2 hours
Stockholm (Sweden) Wednesday, October 14, 2015 at 7:00:00 PM CEST UTC+2 hours
Corresponding UTC (GMT) Wednesday, October 14, 2015 at 5:00:00 PM     

How to use the Time Zone Converter